GlaxoSmithKline

GlaxoSmithKline

GlaxoSmithKline (GSK)GlaxoSmithKline - one of the world's leading research-based pharmaceutical and healthcare companies - is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For more information, visit www.gsk.com.

GlaxoSmithKline RSS Channel

Filters
List of articles in category GlaxoSmithKline
Title Published Date
Government orders for pandemic H1N1 vaccine 13 January 2010
Revolade (eltrombopag) receives positive opinion in Europe for chronic immune thrombocytopenic purpura 22 December 2009
GSK initiates second pivotal Phase III trial for investigational cardiovascular medication Darapladib 11 December 2009
GSK signs agreement with the WHO to donate 50 million doses of pandemic H1N1 vaccine 12 November 2009
Experience of GSK's H1N1 adjuvanted vaccine, Pandemrix™, and preliminary paediatric results 26 October 2009
Results from second clinical trial of GSK's H1N1 adjuvanted vaccine confirm immune response and tolerability 21 October 2009
GSK partners with UK Government and Wellcome Trust to stimulate innovation 15 October 2009
Initial results from first clinical trial of GSK's H1N1 adjuvanted vaccine 14 September 2009
Pandemic (H1N1) 2009 influenza update 15 August 2009
Amgen to collaborate with GSK to commercialize denosumab in Europe for postmenopausal osteoporosis 29 July 2009
WHO grants prequalification to Cervarix®: GSK's vaccine to help combat cervical cancer in developing nations 10 July 2009
GSK and Chroma Therapeutics form alliance to develop novel macrophage-targeted drugs 25 June 2009
GSK announces a strategic alliance with Dr. Reddy's Laboratories Ltd 18 June 2009
World Health Organization grants Global Prequalification to GSK's Rotarix™ vaccine 08 June 2009
GlaxoSmithKline update: A (H1N1) influenza vaccine development 18 May 2009
GlaxoSmithKline update: influenza A (H1N1) 06 May 2009
Emergence of a new H1N1 influenza A strain (swine influenza) 30 April 2009
OTC weight loss aid is available in pharmacies across Europe 21 April 2009
GSK submits Tyverb®/Tykerb® for first-line treatment of metastatic breast cancer in Europe, US 02 April 2009
NICE refuses funding for advanced breast cancer treatment, Tyverb® 05 March 2009
Health data interoperability: Opportunities and threats